SBLOF (Shin Nippon Biomedical Laboratories) Tariff Resilience Score: 6/10 (As of Jun. 29, 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
77 GF Score
Price $9.16
GF Value $14.46
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Tariff Resilience Score?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 77 Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus rates SBLOF with a GF Score™ of 77/100 and a GF Value™ of $14.46. The stock has 5 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Shin Nippon Biomedical Laboratories ranks better than 87.44% on this metric.

Shin Nippon Biomedical Laboratories has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Shin Nippon Biomedical Laboratories has SBLOF's reliance on international research collaborations and supply chains for biomedical products exposes it to tariff risks, though its niche market may offer some protection.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Shin Nippon Biomedical Laboratories might have Average Resilient.

Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Shin Nippon Biomedical Laboratories Tariff Resilience Score Related Terms

SBLOF vs TMO, DHR, IDXX: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shin Nippon Biomedical Laboratories Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Tariff Resilience Score falls into.


SBLOF
77GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a Tariff Resilience Score of 6 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #27 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 12.6%.
Is Shin Nippon Biomedical Laboratories' Tariff Resilience Score too high?
Shin Nippon Biomedical Laboratories' current Tariff Resilience Score is 6. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #27 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Tariff Resilience Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #27 out of 215 companies for Tariff Resilience Score. This places Shin Nippon Biomedical Laboratories in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Shin Nippon Biomedical Laboratories's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Tariff Resilience Score of 6. The stock's GF Value™ is $14.46, compared to a current price of $9.16 — trading 36.6% below its estimated fair value. The current Tariff Resilience Score is 6. Shin Nippon Biomedical Laboratories' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 36.6% below its estimated GF Value™ of $14.46.

Key valuation signals for SBLOF:

  • Tariff Resilience Score: 6
  • GF Value™: $14.46 vs. price of $9.16 (36.6% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
77GF Score

Get the complete analysis for SBLOF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$14.46
GF Value